论文部分内容阅读
目的探讨强力宁与清开灵、胸腺肽不同配伍对病毒性肝炎的疗效。方法病毒性肝炎患者203例，按所给药物不同分成对照组、强力宁组、强力宁加胸腺肽组、强力中加清开灵组进行治疗．观察其降酶、造黄及血清白蛋白的情况。结果用t检验进行统计学分析。结果强力宁及各配伍组对各型肝炎血清白蛋白无影响。在降酶作用中，亚重肝组和慢性肝炎组明显优于对照组．在退黄作用中，各配伍对急性肝炎、慢性肝炎、亚重肝疗效均好。但对肝硬化病人疗效差。结论强力宁及其各配伍（清开灵或胸腺肽）对慢性肝炎及亚急性重症肝炎有明显的降酶、退黄作用。
Objective To investigate the curative effect of different compatibility of Qiangli Ning and Qingkailing and Thymosin on viral hepatitis. Methods Totally 203 patients with viral hepatitis were divided into control group, Qiangliing group, Qiangning plus thymosin group, QKL plus QKL group for treatment. Observed its Jiangni, making yellow and serum albumin situation. Results t test for statistical analysis. Results Qiang Ning and each compatibility group had no effect on serum hepatitis albumin. In the role of Jiangni, sub-heavy liver and chronic hepatitis group was significantly better than the control group. In the role of jaundice, the compatibility of acute hepatitis, chronic hepatitis, sub-heavy liver efficacy are good. However, poor efficacy in patients with cirrhosis. Conclusion Qiangning and its compatibility (Qing Kai Ling or thymosin) on chronic hepatitis and sub-acute severe hepatitis were significantly decreased enzyme, the role of jaundice.